2023 Summit on Cancer Health Disparities: Reframing and addressing barriers to adoption of precision oncology

Seattle, WA US
April 28, 2023 to April 30, 2023

This annual oncology conference, 2023 Summit on Cancer Health Disparities: Reframing and addressing barriers to adoption of precision oncology, will feature lectures, panel discussions and debates among leaders across the spectrum of cancer care delivery. This conference will bring together oncology professionals, cancer disparity researchers, and other stakeholders to discuss the factors leading to cancer health disparities and ways to overcome the impact of these factors to optimize outcomes of cancer patients.

SCHD23 is an accredited continuing education activity (CME activity) that will foster collaborative interdisciplinary interactions and partnerships to stimulate the development of new research and clinical practices that reduce cancer health disparities and improve outcomes of the diverse patient population.

Call for Abstract

Click here to submit abstracts for presentation at this conference. The abstract submission deadline is January 31, 2023.


The top three highest-scoring abstracts submitted by residents or fellows will receive complimentary registration and two free hotel nights during the conference. A resident/fellow/trainee must be the first author of the abstract.

Target Audience

  • Oncologist and Hematologists
  • Oncology and Hematology Nurse Practitioners
  • Oncology and Hematology Physician Assistants
  • Oncology and Hematology Nurses
  • Oncology and Hematology Pharmacists
  • Oncology and Hematology Fellows/Residents
  • Oncology and Hematology Researchers
  • Others interested in cancer disparities


Learning Objectives

Upon successful completion of this educational activity, participants will be able to:

  • Identify drivers of cancer health disparities and review their impact on patients along the cancer continuum.
  • State the financial and physical barriers and review strategies to navigate these factors to optimize the management of patients with cancer.
  • Incorporate evidence-based strategies to minimize the impact of specific drivers of inequity in the management of patients with cancer.
  • Review barriers to using precision-guided cancer care and discuss evidence-based strategies to navigate these barriers to incorporate the new standards of care in managing patients with cancer.
  • Describe challenges and develop novel approaches to improve the participation of underrepresented communities in clinical trials.
Course summary
Course opens: 
Course expires: 
Event starts: 
04/28/2023 - 7:52am PDT
Event ends: 
04/30/2023 - 4:00pm PDT

Preliminary Conference Agenda:

April 28, 2023

08:30 AM to 10:00 AM           Session - Clinical trials

Chair: Dr. Hala Borno

08:30 AM to 08:45 AM           Rising tide of biomarker selected studies - how genomic testing is key to unlocking inequities in oncology clinical trial access - Dr. Hiba Khan

08:45 AM to 09:00 AM           Advanced imaging and stage migration - how finding more  disease may lead to more opportunities

09:00 AM to 09:15 AM           Applying a social determinants of health framework to address clinical trial inequities 

10:00 AM to 10:30 AM           Break 

10:30 AM to 12:00 PM           Session - Immunotherapy and cellular therapy (Track I)

Chair: Dr. Shailender Bhatia

10:30 AM to 12:00 PM           Session – Novel therapies in cancer (Track II) 

Chair: Dr. Mark Pegram 

10:30 AM to 11:00 AM           Keynote lecture - Dr. Vivek Subbiah

11:00 AM to 12:00 PM           Panel discussion and Q & A  - Session speaker + Dr. Parameswaran Hari

12:00 PM to 01:00 PM           Lunch

01:00 PM to 02:30 PM           Session - Access to cancer care in LMIC - navigating current challenges

Chair: Dr. Aparna Parikh 

01:00 PM to 01:20 PM           Developing on Oncology Care Model in an Ultra Low Income Settings 

01:20 PM to 01:35 PM           The Nursing Experience in Botswana: Leading Patient Centered Care - Lorraine Drapek, DNP, FNP-BC, AOCNP

01:35 PM to 01:50 PM           Equitable Partnerships in Global Oncology: Best Practice Examples of a AMCs/LMICs partnership - Dr. Erica Ruiz

01:50 PM to 02:30 PM           Panel/Q&A 

02:30 PM to 04:00 PM           Session - Diagnostics - pathology & radiology (Track I)

Chair: Dr. Ronald Balassanian

02:30 PM to 04:00 PM           Session - Machine learning (Track II)

Chair: Dr. Dan Milner 

04:00 PM to 05:00 PM           Career in Oncology - Success Lounge 

04:00 PM to 04:10 PM           Academic career 

04:10 PM to 04:20 PM           Community practice

04:20 PM to 04:30 PM           Disparities in cancer care

04:30 PM to 05:00 PM           Panel discussion


April 29, 2023

07:30 AM to 08:45 AM           Session – LGBTQ, young adults 

Chair: Dr. David Aboulafia

Creating an International Research Agenda for People Living with HIV and Cancer- Experiences in Uganda and the AIDS Malignancy Consortium  - Dr. Warren Phipps

08:45 AM to 10:00 AM           Session – Plenary session (TBD)

10:00 AM to 10:30 AM           Break

10:30 AM to 12:00 PM           Session - Surgical Oncology (Track I) 

Chair: Dr. Evan Glazer

10:30 AM to 10:55 AM:           Disparities at the interface of systemic therapy and surgery in thoracic oncology

10:55 AM to 11:20 AM:           Identifying opportunities to address disparities in gastrointestinal surgical oncology

11:20 AM to 11:45 AM:           Rural/urban disparities in peri-operative systemic therapy in patients with breast and cutaneous malignancies - Dr. Cristina O'Donoghue

11:45 AM to 12:00 PM:           Panel/Q&A

10:30 AM to 12:00 PM           Session – Radiation Oncology (Track II)

Chair: Lia Moriguchi Halasz, MD 

10:30 AM to 10:45 AM           Global infrastructure for radiotherapy 

10:45 AM to 11:00 AM           Global expertise in radiation oncology - Dr. Benjamin Li

11:00 AM to 11:15 AM           Global expertise in medical physics - Dr. Afua Yorke

11:15 AM to 11:30 AM           Geospatial distribution of US radiotherapy infrastructure - Dr. Solmaz Amiri

11:30 AM to 11:45 AM           Other barriers to radiotherapy in the US - Dr. Gita Suneja

11:45 AM to 12:00 PM           Panel discussion 

12:00 PM to 1:30 PM             Lunch

01:30 PM to 03:00 PM           Session - Private practice and academia (Track I)

Chair: Dr. Ulka Vaishampayan

01:30 PM to 02:00 PM           Gender disparity in academia: Keynote speaker - Dr. Ishwaria Subbiah

02:00 PM to 02:15 PM           Disparities in private practice 

02:15 PM to 03:00 PM           Panel discussion:  Partnership among private practice and academic institutions - innovative models to improve patient care - Dr. Joseph Rosales

01:30 PM to 03:00 PM           Session - APP in oncology practice (Track II)

03:00 PM to 04:30 PM           Session - Career in Cancer Health Disparities - training and funding opportunities (Track I) 

Chair: Dr. Ana Maria Lopez

03:00 PM to 04:30 PM           Session - Current oncology workforce (Avoiding burnout, optimizing patient care) (Track II)

Chair: Dr. Hannah Linden

April 30, 2023

07:00 AM to 08:00 AM           Breakfast and registration

08:00 AM to 09:30 AM           Session - Abstracts

09:30 AM to 10:00 AM             Break 

10:00 AM to 11:45 PM           Session - Screening and early detection (Track I)

Chair: Dr. Robert Smith

10:00 AM to 11:45 PM           Session - Survivorship (Track II)

11:45 AM to 12:00 PM     Adjourn 


Grand Hyatt Seattle
721 Pine St
Seattle, WA 98101
United States


A limited number of rooms have been reserved at the Grand Hyatt Seattle for participants of the 2023 Summit on Cancer Health Disparities (SCHD23). Please reserve your room by Friday, April 7, 2023, for the discounted rate listed below.

Link to book your hotel room  - https://www.hyatt.com/en-US/group-booking/SEAGH/G-SCHD


In the event that a guest does not check into their room on the first night of their reservation, this will be considered a “no show”. Client understands that a no show room is released at midnight for all remaining days of the reservation. Reinstatement of the reservation will be based on hotel availability and cannot be guaranteed. All no shows will be charged a fee of one night’s room and tax to the method of payment used to guarantee the reservation (individual credit card or group master account).


All individual reservations must be guaranteed by credit card when making the reservation. To avoid cancellation fees, guestsmay cancel their reservation by 4pm PST 24 hours prior to their arrival. Guaranteed reservations not cancelled within the 24 hours prior to arrival will be billed to the guest or Group, as appropriate.





Evan Glazer, MD, PhD, FACS, FSSO

has no relevant financial relationships to disclose at this time.

Lia Halasz, MD

has a financial relationship (Grant Or Contract) with Biomimetix;.

Ulka Vaishampayan, MD

has a financial relationship (Professional Services) with BMS;.
has a financial relationship (Professional Services) with Bayer;.
has a financial relationship (Professional Services) with Pfizer;.
has a financial relationship (Professional Services) with Exelixis;.
has a financial relationship (Professional Services) with Merck;.
has a financial relationship (Professional Services) with sanofi;.

Umang Swami, MD, MS

has a financial relationship (Other) with Seattle Genetics;.
has a financial relationship (Other) with Exelixis;.
has a financial relationship (Other) with Astellas;.

Siddhartha Yadav, Siddhartha Yadav, MD, FACP

has no relevant financial relationships to disclose at this time.

Solmaz Amiri, DDes, Msc

has no relevant financial relationships to disclose at this time.

Lorraine Drapek, DNP FNP-BC AOCNP

has no relevant financial relationships to disclose at this time.

Benjamin Li, MD, MBA

has no relevant financial relationships to disclose at this time.

Afua Yorke

has no relevant financial relationships to disclose at this time.

If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information



Please login or register to take this course.


If you do not plan to claim CME credits, you can register here.

If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:

  • If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
  • If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event. 

Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again. 


Refund Policy 

You may cancel your enrollment at any time. Cancellation fees apply as below:

  • 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
  • No refunds will be issued if registration is canceled after that date.  

No credits will be offered if you do not complete all required steps of this activity which include registration, participation in the live activity, and completion of pre & post-tests as well as course evaluations.